The Wnt1::Cre; R26-iDTR transgenic strain used in the study that allows the generation of aganglionosis by focal injection of DT, does not carry any of the genetic defects that have been reported either in HSCR rodent models or in HSCR patients. Here, WNT1 is linked to Hirschsprung disease.